{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:32:44Z","timestamp":1762363964040,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071989","82371911","82372075"],"award-info":[{"award-number":["82071989","82371911","82372075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.acra.2024.11.060","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T16:09:59Z","timestamp":1736438999000},"page":"2090-2098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating Neoadjuvant Immunochemotherapeutic Response for Bladder Carcinoma Using Amide Proton Transfer-Weighted MRI"],"prefix":"10.1016","volume":"32","author":[{"given":"Lingmin","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-7736","authenticated-orcid":false,"given":"Huanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2024.11.060_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2024.11.060_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JU.0000000000002189","article-title":"Four versus 3 cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: implications for pathological response and survival","volume":"207","author":"Patel","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.acra.2024.11.060_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/JU.0000000000002190","article-title":"Identifying the optimal number of neoadjuvant chemotherapy cycles in patients with muscle invasive bladder cancer","volume":"207","author":"D'Andrea","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.acra.2024.11.060_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.eururo.2017.06.012","article-title":"Systematic review of immune checkpoint inhibition in urological cancers","volume":"72","author":"Rijnders","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2024.11.060_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acra.2024.11.060_bib6","article-title":"Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: a\u00a0multi-center real-world retrospective study","volume":"3","author":"Hu","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.acra.2024.11.060_bib7","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1200\/JCO.21.01485","article-title":"Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: a multicenter, single-arm, phase ii trial","volume":"40","author":"Funt","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2024.11.060_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4143\/crt.2022.343","article-title":"Neoadjuvant nivolumab plus gemcitabine\/cisplatin chemotherapy in muscle-invasive urothelial carcinoma of the bladder","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.acra.2024.11.060_bib9","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1200\/JCO.21.01003","article-title":"Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive bladder cancer","volume":"39","author":"Rose","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2024.11.060_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1148\/radiol.2019182718","article-title":"Texture analysis with 3.0-T MRI for association of response to neoadjuvant chemotherapy in breast cancer","volume":"294","author":"Eun","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2024.11.060_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00330-020-07101-3","article-title":"Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer","volume":"31","author":"Yuan","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2024.11.060_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1148\/radiol.2015142979","article-title":"Pre- and posttreatment glioma: comparison of amide proton transfer imaging with MR spectroscopy for biomarkers of tumor proliferation","volume":"278","author":"Park","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2024.11.060_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiol.211986","article-title":"MRI radiomics model predicts pathologic complete response of rectal cancer following chemoradiotherapy","volume":"303","author":"Shin","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2024.11.060_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13058-018-0982-2","article-title":"Amide chemical exchange saturation transfer at 7 T: a possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients","volume":"20","author":"Krikken","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.acra.2024.11.060_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-18-2168","article-title":"Tumor pH and protein concentration contribute to the signal of amide proton transfer magnetic resonance imaging","volume":"79","author":"Ray","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.acra.2024.11.060_bib16","first-page":"1085","article-title":"Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI","volume":"9","author":"Zhou","year":"2003","journal-title":"Nat\u00a0Med"},{"key":"10.1016\/j.acra.2024.11.060_bib17","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/mrm.10651","article-title":"Amide proton transfer (APT) contrast for imaging of brain tumors","volume":"50","author":"Zhou","year":"2003","journal-title":"Magn Reson Med"},{"doi-asserted-by":"crossref","unstructured":"Kong L., Li H., Cai Q., Cao W., Chen Y., Weng B., et al. Amide Proton Transfer-Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer. J Magn Reson Imaging. Published online June 1, 2024.","key":"10.1016\/j.acra.2024.11.060_bib18","DOI":"10.1002\/jmri.29464"},{"issue":"2","key":"10.1016\/j.acra.2024.11.060_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.acra.2023.09.005","article-title":"Amide proton transfer-weighted MRI and diffusion-weighted imaging in bladder cancer: a complementary tool to the VI-RADS","volume":"31","author":"Kong","year":"2024","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.acra.2024.11.060_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1148\/radiol.211804","article-title":"Amide proton transfer-weighted MRI in predicting histologic grade of bladder cancer","volume":"305","author":"Wang","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2024.11.060_bib21","article-title":"Comparative analysis of amide proton transfer and diffusion-weighted imaging for assessing Ki-67, p53 and PD-L1 expression in bladder cancer","author":"Li","year":"2024","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2024.11.060_bib22","article-title":"Predicting treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer using amide proton transfer MRI combined with diffusion-weighted imaging","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2024.11.060_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: a suitable antineoplastic target","volume":"4","author":"Adams","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.acra.2024.11.060_bib24","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ejrad.2015.02.026","article-title":"Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma","volume":"84","author":"Chakiba","year":"2015","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.acra.2024.11.060_bib25","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s00261-021-02963-7","article-title":"Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer","volume":"46","author":"Ahmed","year":"2021","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.acra.2024.11.060_bib26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/mrm.24770","article-title":"Chemical exchange saturation transfer effect in blood","volume":"71","author":"Zheng","year":"2014","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.acra.2024.11.060_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00330-021-08110-6","article-title":"Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer","volume":"32","author":"Kimura","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2024.11.060_bib28","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.ijrobp.2011.11.065","article-title":"Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer","volume":"83","author":"Yoshida","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2024.11.060_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/RLI.0000000000000518","article-title":"Impact of machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy and survival outcomes in breast cancer patients","volume":"54","author":"Tahmassebi","year":"2019","journal-title":"Invest Radiol"},{"issue":"3","key":"10.1016\/j.acra.2024.11.060_bib30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jmri.28570","article-title":"Comparison of MRI and CT-based radiomics and their combination for early identification of pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer","volume":"58","author":"Li","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.acra.2024.11.060_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11547-019-01081-1","article-title":"Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma","volume":"125","author":"Sun","year":"2020","journal-title":"Radiol Med"},{"key":"10.1016\/j.acra.2024.11.060_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiol.2018171804","article-title":"MR imaging with apparent diffusion coefficient histogram analysis: evaluation of locally advanced rectal cancer after chemotherapy and radiation therapy","volume":"288","author":"Enkhbaatar","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2024.11.060_bib33","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00330-020-07217-6","article-title":"Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy","volume":"31","author":"Perucho","year":"2021","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1016\/j.acra.2024.11.060_bib34","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/cancers11101506","article-title":"Whole tumor histogram analysis using DW MRI in primary central nervous system lymphoma correlates with tumor biomarkers and outcome","volume":"11","author":"Chong","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.acra.2024.11.060_bib35","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1007\/s00330-017-5236-7","article-title":"Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?","volume":"28","author":"De Robertis","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2024.11.060_bib36","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2014.512","article-title":"Improving tumour heterogeneity MRI assessment with histograms","volume":"111","author":"Just","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.acra.2024.11.060_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.961393","article-title":"Diffusion-weighted MRI to determine response and long-term clinical outcomes in muscle-invasive bladder cancer following neoadjuvant chemotherapy","volume":"12","author":"Hafeez","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2024.11.060_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12885-023-10760-2","article-title":"Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer","volume":"23","author":"Reijonen","year":"2023","journal-title":"BMC Cancer"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224009346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224009346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:29:44Z","timestamp":1762363784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633224009346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1076633224009346"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2024.11.060","relation":{},"ISSN":["1076-6332"],"issn-type":[{"type":"print","value":"1076-6332"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating Neoadjuvant Immunochemotherapeutic Response for Bladder Carcinoma Using Amide Proton Transfer-Weighted MRI","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2024.11.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}